Kim SH - Search Results

1

Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study.

Park MH, Seo JH, Park JH, Seong MK, Park KU, Kim MK, Chang M, Koh SJ, Lee MH, Lim ST, Yoo YB, Oh SY, Kim SH, Ahn KY, Park TH, Ju H, Baek EH, Kim S, Kim N, Lee E, Kim TH. Park MH, et al. Among authors: kim th, kim sh, kim s, kim n, kim mk. Expert Opin Biol Ther. 2024 Apr;24(4):305-312. doi: 10.1080/14712598.2024.2334386. Epub 2024 Apr 25. Expert Opin Biol Ther. 2024. PMID: 38664937

2

Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial.

Verschraegen C, Andric Z, Moiseenko F, Makharadze T, Shevnya S, Oleksiienko A, Yañez Ruiz E, Kim S, Ahn K, Park T, Park S, Ju H, Ohe Y. Verschraegen C, et al. BioDrugs. 2022 Nov;36(6):749-760. doi: 10.1007/s40259-022-00552-8. Epub 2022 Sep 28. BioDrugs. 2022. PMID: 36169807 Free PMC article. Clinical Trial.

3

Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial.

Stebbing J, Baranau YV, Baryash V, Manikhas A, Moiseyenko V, Dzagnidze G, Zhavrid E, Boliukh D, Pikiel J, Eniu AE, Li RK, Tiangco B, Lee SJ, Kim S. Stebbing J, et al. Breast Cancer Res Treat. 2021 Aug;188(3):631-640. doi: 10.1007/s10549-021-06240-5. Epub 2021 Jun 20. Breast Cancer Res Treat. 2021. PMID: 34148205 Free PMC article. Clinical Trial.

4

Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study.

Buske C, Jurczak W, Sancho JM, Zhavrid E, Kim JS, Hernández-Rivas JÁ, Prokharau A, Vasilica M, Nagarkar R, Kwak L, Kim WS, Lee S, Kim S, Ahn K, Ogura M. Buske C, et al. Blood Adv. 2021 Sep 14;5(17):3354-3361. doi: 10.1182/bloodadvances.2021004484. Blood Adv. 2021. PMID: 34477816 Free PMC article. Clinical Trial.

5

Optimal treatment strategies for small cell carcinoma of the uterine cervix: A retrospective multi-center study (KROG 19-03).

Cho WK, Park W, Kim YS, Kang HC, Kim JH, Kim KS, Choi KH, Chang SK, Ahn KJ, Lee SH, Kim S, Kim J, Eom KY, Lee J, Lee JH, Choi JH. Cho WK, et al. Among authors: kim s, kim ks, kim ys, kim j, kim jh. Eur J Obstet Gynecol Reprod Biol. 2021 Mar;258:396-400. doi: 10.1016/j.ejogrb.2021.01.034. Epub 2021 Jan 22. Eur J Obstet Gynecol Reprod Biol. 2021. PMID: 33545454

6

The prognostic value of the number of metastatic lymph nodes on the long-term survival of intrahepatic cholangiocarcinoma using the SEER database.

Kim J, Han DH, Choi GH, Kim KS, Choi JS, Kim SH. Kim J, et al. Among authors: kim sh, kim ks. J Gastrointest Oncol. 2023 Dec 31;14(6):2511-2520. doi: 10.21037/jgo-23-580. Epub 2023 Dec 27. J Gastrointest Oncol. 2023. PMID: 38196549 Free PMC article.

7

Beneficial effects of modulated electro-hyperthermia during neoadjuvant treatment for locally advanced rectal cancer.

Kim S, Lee JH, Cha J, You SH. Kim S, et al. Int J Hyperthermia. 2021;38(1):144-151. doi: 10.1080/02656736.2021.1877837. Int J Hyperthermia. 2021. PMID: 33557636 Free article.

8

Thirty-day mortality after palliative radiotherapy in advanced cancer patients: Optimizing end-of-life care in Asia.

Kim MS, Cha H, You SH, Kim S. Kim MS, et al. Among authors: kim s. J Med Imaging Radiat Oncol. 2024 Apr;68(3):307-315. doi: 10.1111/1754-9485.13635. Epub 2024 Mar 7. J Med Imaging Radiat Oncol. 2024. PMID: 38450953

9

Long-Term Feasibility of 13.56 MHz Modulated Electro-Hyperthermia-Based Preoperative Thermoradiochemotherapy in Locally Advanced Rectal Cancer.

Lee Y, Kim S, Cha H, Han JH, Choi HJ, Go E, You SH. Lee Y, et al. Among authors: kim s. Cancers (Basel). 2022 Mar 1;14(5):1271. doi: 10.3390/cancers14051271. Cancers (Basel). 2022. PMID: 35267579 Free PMC article.

10

Intensity-Modulated Radiotherapy-Based Reirradiation for Head and Neck Cancer: A Multi-institutional Study by Korean Radiation Oncology Group (KROG 1707).

Lee J, Kim TH, Kim YS, Kim M, Park JW, Kim SH, Kim HJ, Lee CG. Lee J, et al. Among authors: kim hj, kim th, kim sh, kim m, kim ys. Cancer Res Treat. 2020 Oct;52(4):1031-1040. doi: 10.4143/crt.2020.310. Epub 2020 Jul 7. Cancer Res Treat. 2020. PMID: 32632081 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24,504 results

Search Page